What is the address of MEDICADE?

The registered office of MEDICADE is located at Rue de la Haie Gérard, Dion-V. 15, 1325 Chaumont-Gistoux.

Is MEDICADE still active?

Yes. According to the CBE (31 October 2026) MEDICADE is active, legal situation “Normale toestand”, started on 4 May 2021.

Is MEDICADE registered on Peppol?

No, MEDICADE is currently not registered on the Peppol network.

What is the enterprise number of MEDICADE?

The enterprise number of MEDICADE is BE0767826462.

When was MEDICADE founded?

MEDICADE was founded on 4 May 2021.

Who are the directors of MEDICADE?

According to the 2025 annual accounts, the directors of MEDICADE are: Nathanaëlle Caprace, Noah Deswysen.

Is MEDICADE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 May 2021; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDICADE make in 2025?

MEDICADE posted a profit after taxes of € 28,280 in financial year 2025.

What is the revenue of MEDICADE?

As a small company, MEDICADE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 56,936.

MEDICADE (Private Limited) - Chaumont-Gistoux

Dossier MEDICADE, printed on 1 November 2026 from databakkes.be/en/0767826462/medicade. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDICADE from Chaumont-Gistoux, company number BE0767826462, closed financial year 2025 with a result of € 28,280 after tax. For that financial year MEDICADE recorded a gross margin of € 56,936 and equity of € 57,891. Compared with financial year 2024, the result moved from € 21,705 to € 28,280. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Healthy

€ 57,891

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 28,280

▲ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 82,998

▼ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 28,280 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 17,946

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 53,134

▼ 27% vs 2024

€ 20,238 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,822

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,640

▲ € 7,561 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 19,999 Gross margin 2022: € 19,999 First fiscal year in the series	€ 38,466 Gross margin 2023: € 38,466 ▲ 92% vs 2022 (€ 19,999) Favourable step	€ 47,510 Gross margin 2024: € 47,510 ▲ 24% vs 2023 (€ 38,466) Favourable step	€ 56,936 Gross margin 2025: € 56,936 ▲ 20% vs 2024 (€ 47,510) Favourable step	▲ 20%
Profit after taxes	€ 3,903 Profit after taxes 2022: € 3,903 First fiscal year in the series	€ 15,186 Profit after taxes 2023: € 15,186 ▲ 289% vs 2022 (€ 3,903) Favourable step	€ 21,705 Profit after taxes 2024: € 21,705 ▲ 43% vs 2023 (€ 15,186) Favourable step	€ 28,280 Profit after taxes 2025: € 28,280 ▲ 30% vs 2024 (€ 21,705) Favourable step	▲ 30%
Equity	€ 23,400 Equity 2022: € 23,400 First fiscal year in the series	€ 38,586 Equity 2023: € 38,586 ▲ 65% vs 2022 (€ 23,400) Favourable step	€ 57,891 Equity 2024: € 57,891 ▲ 50% vs 2023 (€ 38,586) Favourable step	€ 57,891 Equity 2025: € 57,891 Unchanged (€ 57,891) Unchanged
Total debts	€ 124,402 Total debts 2022: € 124,402 First fiscal year in the series	€ 142,687 Total debts 2023: € 142,687 ▲ 15% vs 2022 (€ 124,402) Unfavourable step	€ 120,468 Total debts 2024: € 120,468 ▼ 16% vs 2023 (€ 142,687) Favourable step	€ 104,011 Total debts 2025: € 104,011 ▼ 14% vs 2024 (€ 120,468) Favourable step	▼ 14%
Cash	€ 61,028 Cash 2022: € 61,028 First fiscal year in the series	€ 70,774 Cash 2023: € 70,774 ▲ 16% vs 2022 (€ 61,028) Favourable step	€ 85,619 Cash 2024: € 85,619 ▲ 21% vs 2023 (€ 70,774) Favourable step	€ 82,998 Cash 2025: € 82,998 ▼ 3% vs 2024 (€ 85,619) Unfavourable step	▼ 3%
Retained profit	€ 20,400 Retained profit 2022: € 20,400 First fiscal year in the series	€ 35,586 Retained profit 2023: € 35,586 ▲ 74% vs 2022 (€ 20,400) Favourable step	€ 54,891 Retained profit 2024: € 54,891 ▲ 54% vs 2023 (€ 35,586) Favourable step	€ 54,891 Retained profit 2025: € 54,891 Unchanged (€ 54,891) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 28,280 Dividend 2025: € 28,280 Unchanged (€ 0) Unchanged
Bank debt	€ 80,456 Bank debt 2022: € 80,456 First fiscal year in the series	€ 92,413 Bank debt 2023: € 92,413 ▲ 15% vs 2022 (€ 80,456) Unfavourable step	€ 72,970 Bank debt 2024: € 72,970 ▼ 21% vs 2023 (€ 92,413) Favourable step	€ 53,134 Bank debt 2025: € 53,134 ▼ 27% vs 2024 (€ 72,970) Favourable step	▼ 27%
Balance sheet total	€ 147,803 Balance sheet total 2022: € 147,803 First fiscal year in the series	€ 181,273 Balance sheet total 2023: € 181,273 ▲ 23% vs 2022 (€ 147,803) Unchanged	€ 178,359 Balance sheet total 2024: € 178,359 ▼ 2% vs 2023 (€ 181,273) Unchanged	€ 161,902 Balance sheet total 2025: € 161,902 ▼ 9% vs 2024 (€ 178,359) Unchanged	▼ 9%

Key figures of MEDICADE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICADE?

What happened at MEDICADE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 28,280 (▲ 30% vs 2024). filed late Source: NBB ↗
May 4, 2021 New establishment in Schaarbeek. KBO
May 4, 2021 Start of the company according to the CBE. KBO

In short

From € 3,903 profit in 2022 to € 28,280 profit in 2025.

Paid € 19,745 in corporate taxes since 2022.

Best year ever: 2025, with € 28,280 profit.

Paid out € 28,280 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Nathanaëlle Caprace Noah Deswysen

MEDISC

MEDICADE

Behind MEDICADE are Nathanaëlle Caprace and Noah Deswysen. Nathanaëlle Caprace is also behind MEDISC.

Directors

According to the 2025 annual accounts

Nathanaëlle Caprace

Director

Also active at: MEDISC

Noah Deswysen

Associate

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Haie Gérard, Dion-V. 15

1325 Chaumont-Gistoux

2.317.243.886

Jean Jaurèslaan 36

1030 Schaarbeek

Active since 4 May 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0767.826.462
VAT number: BE 0767.826.462
Registered office: Rue de la Haie Gérard, Dion-V. 15, 1325 Chaumont-Gistoux
Names & denominations: MEDICADE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 May 2021
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗